+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ambrx Inc - logo

Ambrx is a biopharmaceutical company that produces protein therapeutics which reduce frequency of dosing, and optimizes efficiency and safety. Ambrx, Inc. was founded in 2003 and is based in La Jolla, California. The company collaborates with Mabspace Biosciences for oncology purposes in China and internationally. They develop a range of products such as ADC, long-acting protein product candidates, collaboration product and product candidates, and other early-stage programs.

HER2 Positive Breast Cancer - Pipeline Insight, 2022 - Product Thumbnail Image

HER2 Positive Breast Cancer - Pipeline Insight, 2022

  • Drug Pipelines
  • July 2022
  • 200 Pages
  • Global
From
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

  • Report
  • January 2020
  • 410 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2021 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2021

  • Drug Pipelines
  • October 2021
  • 60 Pages
  • Global
From
From
Monoclonal Antibody Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2016-2023

  • Report
  • November 2023
  • 500 Pages
  • Global
From
From
From
From
Antibody Drug Conjugates Market Report 2022-2032 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2022-2032

  • Report
  • November 2022
  • 434 Pages
  • Global
From
Human Growth Hormone Drugs - Global Strategic Business Report - Product Thumbnail Image

Human Growth Hormone Drugs - Global Strategic Business Report

  • Report
  • December 2023
  • 335 Pages
  • Global
From
From
From
Loading Indicator